Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
April 7, 2009
[Two cases of a nonfunctioning pancreatic endocrine tumor found on a medical checkup]
Kouki Nio, Tetsuro Shimakami, Taro Yamashita, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 20, 2005
Pretreatment prediction of interferon-alfa efficacy in chronic hepatitis C patients
Kazuhiro Hayashida, Akito Daiba, Akito Sakai, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
April 28, 2026
Evidence for Itinerant Ferromagnetic Flat Bands Producing Large Transverse Responses
Susumu Minami, Yangming Wang, Seigo Souma, et al.
Gastroenterology
|
April 5, 2011
Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C
Masao Honda, Kenji Takehana, Akito Sakai, et al.
Journal of Hepatology
|
December 7, 2010
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
Masayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, et al.
Nature Communications
|
April 18, 2025
Zero-field Hall effect emerging from a non-Fermi liquid in a collinear antiferromagnet V<sub>1/3</sub>NbS<sub>2</sub>
Mayukh Kumar Ray, Mingxuan Fu, Youzhe Chen, et al.
Internal Medicine (Tokyo, Japan)
|
December 17, 2013
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan
Akira Sato, Michio Sata, Kenji Ikeda, et al.
Nature Genetics
|
September 15, 2009
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|
April 7, 2009
[Two cases of a nonfunctioning pancreatic endocrine tumor found on a medical checkup]
Kouki Nio, Tetsuro Shimakami, Taro Yamashita, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 20, 2005
Pretreatment prediction of interferon-alfa efficacy in chronic hepatitis C patients
Kazuhiro Hayashida, Akito Daiba, Akito Sakai, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
April 28, 2026
Evidence for Itinerant Ferromagnetic Flat Bands Producing Large Transverse Responses
Susumu Minami, Yangming Wang, Seigo Souma, et al.
Gastroenterology
|
April 5, 2011
Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C
Masao Honda, Kenji Takehana, Akito Sakai, et al.
Journal of Hepatology
|
December 7, 2010
Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
Masayuki Kurosaki, Yasuhito Tanaka, Nao Nishida, et al.
Nature Communications
|
April 18, 2025
Zero-field Hall effect emerging from a non-Fermi liquid in a collinear antiferromagnet V<sub>1/3</sub>NbS<sub>2</sub>
Mayukh Kumar Ray, Mingxuan Fu, Youzhe Chen, et al.
Internal Medicine (Tokyo, Japan)
|
December 17, 2013
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan
Akira Sato, Michio Sata, Kenji Ikeda, et al.
Nature Genetics
|
September 15, 2009
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama, et al.
Page
of 6